Glucose Injection (Baxter)

Quốc gia: New Zealand

Ngôn ngữ: Tiếng Anh

Nguồn: Medsafe (Medicines Safety Authority)

Thành phần hoạt chất:

Glucose monohydrate 70%

Sẵn có từ:

Baxter Healthcare Ltd

INN (Tên quốc tế):

Glucose monohydrate 70%

Liều dùng:

70 %

Dạng dược phẩm:

Solution for infusion

Thành phần:

Active: Glucose monohydrate 70%

Các đơn vị trong gói:

Bag, plastic, 500 mL

Lớp học:

General sale

Loại thuốc theo toa:

General sale

Sản xuất bởi:

Baxter Healthcare Corporation

Chỉ dẫn điều trị:

Hypertonic infusion solutions are indicated: - As a source of energy incorporated with parenteral nutrition with minimal dilution effect - For use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) The alimentary tract cannot or should not be used b) Gastrointestinal absorption of protein is impaired c) Metabolic requirements for protein are substantially increased, as with extensive burns.

Tóm tắt sản phẩm:

Package - Contents - Shelf Life: Bag, plastic, - 500 mL - 24 months from date of manufacture stored at or below 30°C

Ngày ủy quyền:

1977-09-06

Đặc tính sản phẩm

NEW ZEALAND DATA SHEET
Glucose (Viaflex) Data Sheet 26 September 2019
Page 1 of 14
Baxter Healthcare Ltd
1 GLUCOSE INJECTION (BAXTER), (solution for infusion)
GLUCOSE Injection (Baxter)
5% solution for infusion
Glucose Injection (Baxter)
10% solution for infusion
Glucose Injection (Baxter)
25% solution for infusion
Glucose Injection (Baxter)
50% solution for infusion
Glucose Injection (Baxter)
70% solution for infusion
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
_Active ingredient _
The active ingredient is glucose (monohydrate).
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Solution for infusion.
Glucose Injection (Baxter) are clear slightly coloured solutions for
intravenous (IV) infusion, in a
Viaflex® plastic bag.
The Glucose Injection (Baxter) infusion preparations are sterile,
non‐pyrogenic parenteral solutions.
They do not contain an antimicrobial agent or added buffer, and have a
pH of 3.5 ‐ 6.5 for 5% to 25%
glucose
concentrations,
and
a
pH
of
3.2
–
6.5
for
50%
to
70%
glucose
concentrations.
The
concentrations of glucose dissolved in a litre of Water for Injections
and their isotonicity are shown in
Tables 1 and 2 (see section 6.5).
The Glucose Injection (Baxter) 5% infusion is an _isotonic_ solution,
whereas Glucose Injection (Baxter)

10% infusions are _hypertonic_.
4 CLINICAL PARTICULARS
4.1
Therapeutic indications
Isotonic (Glucose Injection (Baxter) 5%) infusion solutions are mainly
indicated:

Whenever non‐electrolyte fluid replacement is required

As a vehicle for drug delivery, provided that the added components are
compatible with glucose.
Hypertonic (Glucose Injection (Baxter)

10%) infusion solutions are indicated:

As a source of energy incorporated with parenteral nutrition with
minimal dilution effect

For use with an appropriate protein (nitrogen) source in the
prevention of nitrogen loss or in the
treatment of negative nitrogen balance in patients where:
a)
the alimentary tract cannot or should not be used
b)
gastrointestinal absorption